Publications
Detailed Information
Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Eom, Sang-Yong | - |
dc.contributor.author | Zhang, Yan Wei | - |
dc.contributor.author | Kim, Sung-Hoon | - |
dc.contributor.author | Choe, Kang-Hyeon | - |
dc.contributor.author | Park, Jung-Duck | - |
dc.contributor.author | Kim, Yong-Dae | - |
dc.contributor.author | Kim, Heon | - |
dc.contributor.author | Kang, Jong-Won | - |
dc.contributor.author | Hong, Yun-Chul | - |
dc.contributor.author | Lee, Kye Young | - |
dc.date.accessioned | 2012-06-08T07:43:03Z | - |
dc.date.available | 2012-06-08T07:43:03Z | - |
dc.date.issued | 2009-03 | - |
dc.identifier.citation | CANCER CAUSES & CONTROL; Vol.20 2; 137-145 | ko_KR |
dc.identifier.issn | 0957-5243 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76923 | - |
dc.description.abstract | Objectives We investigated the association of genetic polymorphisms of NQO1, ALDH2, CYP2E1, and the combined genotype of these genes on lung cancer risk, and also evaluated the association after stratification by cumulative smoking amounts and alcohol drinking levels. Methods The case-control study was performed in 387 lung cancer patients and 387 age- and sex-matched cancer-free controls. Direct interview was conducted and the genotypes of NQO1, ALDH2, and CYP2E1 were investigated using PCR-RFLP or 50-nuclease activity assay. Results The proportion of individuals with occupational history of mining was significantly higher in cases than in controls. The risk of lung cancer was significantly lower in light-drinkers (<108 g/week) than non-drinkers. The NQO1 Pro/Ser + Ser/Ser genotype showed an increased risk for lung cancer with a marginal significance (OR = 1.35, 95% CI = 0.99-1.86) compared with NQO1 Pro/Pro genotype. In heavy-smokers, the combination of NQO1 Pro/Ser + Ser/Ser and CYP2E1 c1/c1 genotype was associated with a significantly increased risk for lung cancer (OR = 2.25, 95% CI = 1.14-4.43) compared with those of NQO1 Pro/Pro and CYP2E1 c1/c2 + c2/c2 genotype. We found a significant interaction between alcohol drinking level and the CYP2E1 genotype (P = 0.0227). Conclusions Our result suggests that the risk of lung cancer is affected by smoking, alcohol drinking, and the genetic polymorphism of NQO1. In particular, genetic polymorphisms for NQO1, CYP2E1, and ALDH2 synergistically with cumulative smoking amounts and alcohol drinking levels interact in the carcinogenesis of lung cancer in Koreans. | ko_KR |
dc.description.sponsorship | This study was supported by the Eco-technopia
21 project of Ministry of Environment, South Korea. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | SPRINGER | ko_KR |
dc.subject | Lung cancer | ko_KR |
dc.subject | Genetic polymorphism | ko_KR |
dc.subject | Alcohol drinking | ko_KR |
dc.subject | Smoking | ko_KR |
dc.title | Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 엄상용 | - |
dc.contributor.AlternativeAuthor | 김성훈 | - |
dc.contributor.AlternativeAuthor | 최강현 | - |
dc.contributor.AlternativeAuthor | 이계영 | - |
dc.contributor.AlternativeAuthor | 박정덕 | - |
dc.contributor.AlternativeAuthor | 홍윤철 | - |
dc.contributor.AlternativeAuthor | 김용대 | - |
dc.contributor.AlternativeAuthor | 강종원 | - |
dc.contributor.AlternativeAuthor | 김헌 | - |
dc.identifier.doi | 10.1007/s10552-008-9225-7 | - |
dc.citation.journaltitle | CANCER CAUSES & CONTROL | - |
dc.description.citedreference | Yang M, 2007, LUNG CANCER, V57, P135, DOI 10.1016/j.lungcan.2007.03.005 | - |
dc.description.citedreference | Minegishi Y, 2007, CANCER, V110, P353, DOI 10.1002/cncr.22795 | - |
dc.description.citedreference | Gresner P, 2007, LUNG CANCER, V57, P1, DOI 10.1016/j.lungcan.2007.02.002 | - |
dc.description.citedreference | Vineis P, 2007, ANN ONCOL, V18, P1230, DOI 10.1093/annonc/mdm109 | - |
dc.description.citedreference | Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200 | - |
dc.description.citedreference | Chao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899 | - |
dc.description.citedreference | Saldivar SJ, 2005, MUTAT RES-GEN TOX EN, V582, P71, DOI 10.1016/j.mrgentox.2004.12.010 | - |
dc.description.citedreference | Bock CH, 2005, CARCINOGENESIS, V26, P381, DOI 10.1093/carcin/bgh314 | - |
dc.description.citedreference | PAUL N, 2004, MUTAT RES, V555, P149, DOI DOI 10.1016/J.MRFMMM.2004.05.023 | - |
dc.description.citedreference | Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227 | - |
dc.description.citedreference | Wang JW, 2003, CANCER SCI, V94, P448 | - |
dc.description.citedreference | Yang M, 2002, LUNG CANCER-J IASLC, V38, P15 | - |
dc.description.citedreference | De Stefani E, 2002, LUNG CANCER-J IASLC, V38, P9 | - |
dc.description.citedreference | Sunaga N, 2002, CANCER EPIDEM BIOMAR, V11, P730 | - |
dc.description.citedreference | Kuper H, 2002, J INTERN MED, V251, P455 | - |
dc.description.citedreference | Lewis SJ, 2001, LUNG CANCER-J IASLC, V34, P177 | - |
dc.description.citedreference | Agarwal DP, 2001, PATHOL BIOL, V49, P703 | - |
dc.description.citedreference | Bandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813 | - |
dc.description.citedreference | Yin L, 2001, LUNG CANCER-J IASLC, V33, P133 | - |
dc.description.citedreference | LI LX, 2001, CANCER EPIDEM BIOMAR, V10, P303 | - |
dc.description.citedreference | Ross D, 2000, CHEM-BIOL INTERACT, V129, P77 | - |
dc.description.citedreference | Wang SL, 1999, LUNG CANCER-J IASLC, V26, P27 | - |
dc.description.citedreference | Prescott E, 1999, AM J EPIDEMIOL, V149, P463 | - |
dc.description.citedreference | MARCHAND LL, 1999, CANCER EPIDEM BIOMAR, V8, P495 | - |
dc.description.citedreference | Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383 | - |
dc.description.citedreference | Chen WQ, 1998, CHEM RES TOXICOL, V11, P295 | - |
dc.description.citedreference | Radjendirane V, 1998, J BIOL CHEM, V273, P7382 | - |
dc.description.citedreference | Hori H, 1997, J CLIN GASTROENTEROL, V25, P568 | - |
dc.description.citedreference | Traver RD, 1997, BRIT J CANCER, V75, P69 | - |
dc.description.citedreference | BANDERA EV, 1997, CANCER CAUSE CONTROL, V8, P819, DOI DOI 10.1023/A:1018456127018 | - |
dc.description.citedreference | Tampo Y, 1996, ARCH BIOCHEM BIOPHYS, V334, P163 | - |
dc.description.citedreference | Kim RB, 1996, J PHARMACOL EXP THER, V279, P4 | - |
dc.description.citedreference | Peto R, 1996, BRIT MED BULL, V52, P12 | - |
dc.description.citedreference | KUEHL BL, 1995, BRIT J CANCER, V72, P555 | - |
dc.description.citedreference | DALY AK, 1994, ENVIRON HEALTH PERSP, V102, P55 | - |
dc.description.citedreference | GASDASKA PY, 1993, CANCER RES, V53, P5458 | - |
dc.description.citedreference | BECKETT WS, 1993, CLIN CHEST MED, V14, P1 | - |
dc.description.citedreference | KOOP DR, 1992, FASEB J, V6, P724 | - |
dc.description.citedreference | HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559 | - |
dc.description.citedreference | GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168 | - |
dc.description.citedreference | ENOMOTO N, 1991, ALCOHOL CLIN EXP RES, V15, P141 | - |
dc.description.citedreference | HARADA S, 1989, ELECTROPHORESIS, V10, P652 | - |
dc.description.citedreference | KONO S, 1986, INT J EPIDEMIOL, V15, P527 | - |
dc.description.tc | 10 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.